Tin tức & Cập nhật

People with cataracts may be at elevated risk of vascular dementia and reduced total brain volumes by way of vascular and non-Alzheimer’s disease (AD) mechanisms, according to a study.

More than one-fifth of patients with acute cerebral ischaemia (ACI) appear to be receiving statins unnecessarily, which has the potential to cause higher than 5,600 adverse events (AEs) each year, including diabetes, myopathy, and eye disease, according to the results of a meta-analysis.

Individuals who received systemic fluoroquinolone do not appear to have an increased risk of uveitis or retinal detachment, as shown in a study.

Supplementation with the re-esterified triglyceride (rTG) form of omega-3 fatty acid does not help ameliorate the symptoms of dry eye disease (DED) associated with meibomian gland dysfunction, as shown in a study.

In the treatment of patients with axial spondyloarthritis (axSpA), the dual IL-17A/F inhibitor bimekizumab appears to lower the risk of uveitis, according to a study.

The use of Janus kinase (JAK) inhibitors in the treatment of major autoimmune diseases appears to reduce the risk of age-related macular degeneration (AMD) for people above 40 years of age, according to a study.

New drug applications approved by US FDA as of 16-30 June 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.